Nine Masts Capital LTD Exact Sciences Corp Transaction History

Nine Masts Capital LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$90.37 - $122.49 $83,592 - $113,303	-925 Closed	0 $0
Q2 2019 Aug 08, 2019	SELL	$89.51 - $118.04 $294,398 - $388,233	-3,289 Reduced 78.05%	925 $109,000
Q1 2019 May 06, 2019	BUY	$61.98 - $96.5 $116,584 - $181,516	1,881 Added 80.63%	4,214 $365,000
Q4 2018 Feb 14, 2019	BUY	$56.04 - $82.66 $50,884 - $75,055	908 Added 63.72%	2,333 $147,000
Q3 2018 Nov 16, 2018	BUY	$48.29 - $80.6 $68,813 - $114,854	1,425 New	1,425 $112,000
Q2 2018 Aug 13, 2018	SELL	$37.84 - $69.96 $742,874 - $1.37 Million	-19,632 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$39.82 - $57.53 $532,194 - $768,888	13,365 Added 213.26%	19,632 $792,000
Q4 2017 Feb 12, 2018	BUY	$46.49 - $60.51 $291,352 - $379,216	6,267	6,267 $329,000

671

163M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.73B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Nine Masts Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Nine Masts Capital LTD with notifications on news.